Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A166 in Refractory HER2-positive Breast Cancer
NCT05346328Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sertraline in breast cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
sertraline
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05346328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05346328.